Oncology & Cancer

Sartans improve survival, time to recurrence in liver cancer

(HealthDay)—For patients with hepatocellular carcinoma after radiofrequency ablation, angiotensin II receptor 1 blockers (sartans) correlate with significantly improved overall survival and time to recurrence, according ...

Cardiology

Antiarrhythmia drugs no impact on late AF recurrence

In patients with atrial fibrillation (AF) treated with radiofrequency catheter ablation, the addition of antiarrhythmic drugs (AADs) for 90 days after the procedure did not reduce arrhythmia recurrence rates at one year, ...

Diseases, Conditions, Syndromes

Review: radioablation offers no benefit for GERD patients

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), evidence shows no difference in physiologic parameters for treatment with a radiofrequency ablation technique known as Stretta versus sham or proton ...

Oncology & Cancer

Radiofrequency ablation effectively treats Barrett's esophagus

Radiofrequency ablation (RFA) leads to remission for 91 percent of patients with dysplastic Barrett's esophagus, according to new figures published in Clinical Gastroenterology and Hepatology, the official clinical practice ...

page 3 from 4